Form 4: Madrigal Pharmaceuticals Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Robert E. Waltermire, Senior VP of Madrigal Pharmaceuticals, sold 103 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On January 24, 2025, Robert E. Waltermire, Senior VP of Madrigal Pharmaceuticals, sold 103 shares of common stock at a price of $335.24 per share.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- Following the transaction, Waltermire directly owns 4,955 shares of Madrigal Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations and doesn't necessarily indicate a positive or negative outlook on the company.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This transaction is related to tax obligations and may not reflect a change in the executive's long-term outlook for the company.
Key Dates
| Date | Description |
|---|---|
| 01/24/2025 | Date of stock sale transaction |
| 01/27/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.